Eva Sevick

9PUBLICATIONS
17CO-AUTHORS
Predictive and prognostic markersTumour immunologyMechanobiologyTissue engineeringCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Sep 26, 2026
SIRT1 Promotes Breast Cancer Stem Cell-Associated Properties and Represents a Potential Therapeutic Target.

|May 04, 2026
Turep: Detecting cross-cancer tumor-reactive T cells in single-cell and spatial transcriptomics data.

|Oct 18, 2024
EPHB4-RASA1 Inhibition of PIEZO1 Ras Activation Drives Lymphatic Valvulogenesis.

Di Chen, Yipei Tang, Philip E Lapinski

|Dec 04, 2023
An EPHB4-RASA1 signaling complex inhibits shear stress-induced Ras-MAPK activation in lymphatic endothelial cells to promote the development of lymphatic vessel valves.

Di Chen, David Wiggins, Eva M Sevick

|Feb 11, 2023
Plasma Cytokines/Chemokines as Predictive Biomarkers for Lymphedema in Breast Cancer Patients.

Anna R Vang, Simona F Shaitelman, John C Rasmussen

|Apr 12, 2022
Enhanced T-Cell Priming and Improved Anti-Tumor Immunity through Lymphatic Delivery of Checkpoint Blockade Immunotherapy.

Carolina Mantilla-Rojas, Fred C Velasquez, Janelle E Morton

Pageof 2

Frequent Collaborators

1 joint publications

Di Chen

1 joint publications

Yipei Tang

1 joint publications

Philip D King

1 joint publications

John C Rasmussen